CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Omega Liquidating Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Omega Liquidating Inc
140 First Street, Suite 501
Phone: (617) 949-4360p:617 949-4360 CAMBRIDGE, MA  02141  United States Ticker: OMGAQOMGAQ
Filed for Bankruptcy on 2/10/2025
This company ceased filing statements with the SEC on 3/31/2025.
Case #25-10211, filed in the U.S. Bankruptcy Court for the District of Delaware
Business Summary
Omega Liquidating, Inc., formerly Omega Therapeutics, Inc., was a clinical-stage biotechnology company, which was engaged in the development of a programmable epigenomic mRNA medicine to treat or cure a broad range of diseases. The Company has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code. The Company remains in possession of its assets and continues to operate its business as a debtor in possession.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYesYes--

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director KaanCertel 54 11/14/2024 5/29/2024
Principal Financial Officer, Senior Vice President - Finance, Principal Accounting Officer Barbara Y.Chan 60 5/31/2024 5/1/2020
Chief Legal and Administrative Officer LingZeng 55 3/1/2022 3/1/2022
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Omega Therapeutics Security Corporation
OMGA
OMGAQ

General Information
Number of Employees: 93 (As of 12/31/2023)
Outstanding Shares: 55,366,213 (As of 11/8/2024)
Shareholders: 79
Stock Exchange: OTC
Federal Tax Id: 813247585
Fax Number: (302) 655-5049


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 11, 2025